Management of Patients with Multidrug-Resistant Organisms in Outpatient Dialysis Facilities
Clin J Am Soc Nephrol
.
2023 Dec 27;19(5):656-659.
doi: 10.2215/CJN.0000000000000419.
Online ahead of print.
Authors
Mary Dittrich
1
,
Jeffrey Silberzweig
2
,
Jeffrey L Hymes
3
,
Jeff Giullian
4
,
Gopa Green
5
,
Leslie P Wong
6
,
Barry I Freedman
7
,
J Ganesh Bhat
8
,
Leslie Spry
9
,
Robert Taylor
10
,
Richard Spech
11
,
Raghu Durvasula
12
,
Sky R Blue
13
Affiliations
1
U.S. Renal Care, Plano, Texas.
2
The Rogosin Institute, Weill Cornell Medical College, New York, New York.
3
Care Delivery, Fresenius Kidney Care, Waltham, Massachusetts.
4
Davita, Inc., Denver, Colorado.
5
Satellite Healthcare, San Jose, California.
6
Intermountain Health, Murray, Utah.
7
Health Systems Management, Inc., Tifton, Georgia.
8
Atlantic Dialysis Management Services, New York, New York.
9
Fresenius Kidney Care, Waltham, Massachusetts.
10
REACH/Dialysis Clinic, Inc., Nashville, Tennessee.
11
Centers for Dialysis Care, Cleveland, Ohio.
12
Puget Sound Kidney Centers, Everett, Washington.
13
Sawtooth Epidemiology and Infectious Diseases, Boise, Idaho.
PMID:
38150244
PMCID:
PMC11108247
(available on
2025-05-01
)
DOI:
10.2215/CJN.0000000000000419
No abstract available